Aeterna Zentaris Inc. AEZS
Set alert
At close · Aug 8
- Open
- 5.51
- Prev close
- 5.72
- Mkt cap
- 17.51M
- Vol
- 7.51K
- Avg vol
- 6.04K
- EPS
- -2.31
- P/E
- -2.48
- Div yield
- 0.00%
More statistics
- Low
- 5.48
- High
- 5.93
- Forward P/E
- -1.70
- Beta
- 2.26
- Short ratio
- 0.37
- Inst. own
- 5.21%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 5.61
- 200-d avg
- 5.42
- 1y target
- 0.00
News
2 years ago globenewswire.com
Aeterna Zentaris Inc. Announces Name Change to COSCIENS Biopharma Inc.
TORONTO, ONTARIO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (formerly Aeterna Zentaris Inc.) (NASDAQ: AEZS) (TSX: AEZS) ("COSCIENS" or the "Company"), a specialty biopharmaceutical…
2 years ago globenewswire.com
Aeterna Zentaris Announces Results of Virtual 2024 Meeting of Shareholders
TORONTO, ONTARIO, July 16, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna" or the "Company"), a specialty biopharmaceutical company developing and commercializing…
2 years ago globenewswire.com
Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
Company expects to report top-line data and complete study results in Q3 2024 TORONTO, ONTARIO, June 13, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the…
2 years ago prnewswire.com
Shareholder Alert: Ademi LLP investigates whether Aeterna Zentaris Inc.'s transaction with Ceapro was Fair to Shareholders
MILWAUKEE , June 7, 2024 /PRNewswire/ -- Ademi LLP is investigating Aeterna (Nasdaq: AEZS) for possible breaches of fiduciary duty and other violations of law in its transaction with Ceapro. Click…
2 years ago globenewswire.com
Aeterna Zentaris and Ceapro Complete Merger Transaction
TORONTO and EDMONTON, June 03, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”) and Ceapro Inc. (TSX-V: CZO) (OTCQX: CRPOF) (“Ceapro”), two…
2 years ago globenewswire.com
Aeterna Zentaris Provides Update on Timing for Annual Meeting of Shareholders and Due Bill Redemption Date
TORONTO, ONTARIO, May 29, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing…
2 years ago globenewswire.com
Aeterna Zentaris Announces Details Regarding Transaction with Ceapro
TORONTO, ON, May 17, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”) announces that it has finalized certain details regarding the previously…
2 years ago globenewswire.com
Aeterna Zentaris Reports First Quarter 2024 Financial Results
TORONTO, ONTARIO, May 14, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing…
2 years ago globenewswire.com
Aeterna Zentaris Announces Effective Date of Share Consolidation
TORONTO, ON, May 01, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”) announces that it has filed articles of amendment to effect the previously…
2 years ago globenewswire.com
Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris
TORONTO and EDMONTON, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna") and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro”) are pleased to announce…
2 years ago zacks.com
Aeterna Zentaris (AEZS) Reports Q4 Loss, Tops Revenue Estimates
Aeterna Zentaris (AEZS) came out with a quarterly loss of $1.16 per share versus the Zacks Consensus Estimate of a loss of $0.97. This compares to loss of $0.84 per share a year ago.
2 years ago globenewswire.com
Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
- Company confirms successful completion of enrollment in the pivotal DETECT Phase 3 trial
2 years ago globenewswire.com
Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
TORONTO and EDMONTON, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna”) and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro”) are pleased to announce…
2 years ago globenewswire.com
Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company
TORONTO and EDMONTON, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna Zentaris”) and Ceapro Inc. (TSXV: CZO) (OTCQX: CRPOF) (“Ceapro”), two innovative…
2 years ago globenewswire.com
Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with Ceapro
TORONTO, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna") today announced that it has issued a Letter to Shareholders and Management Proxy Circular ahead…
2 years ago businesswire.com
AEZS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aeterna Zentaris Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Aeterna Zentaris Inc. (NASDAQ: AEZS) and Ceapro Inc. is fair to Aeterna shareholders.…
2 years ago globenewswire.com
Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical Company
TORONTO and EDMONTON, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna”) and Ceapro Inc. (TSXV: CZO) (OTCQX: CRPOF) (“Ceapro”), two innovative…
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 369 companies hit new 52-week lows.
3 years ago zacks.com
Aeterna Zentaris (AEZS) Reports Q2 Loss, Tops Revenue Estimates
Aeterna Zentaris (AEZS) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.87. This compares to loss of $0.87 per share a year ago.
3 years ago globenewswire.com
Aeterna Zentaris Reports Second Quarter 2023 Financial Results
TORONTO, ONTARIO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing…
3 years ago globenewswire.com
Aeterna Zentaris Outlines Progress on Development Pipeline Programs and Provides Corporate Update
TORONTO, ONTARIO, July 13, 2023 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing…
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday, 93 stocks made new 52-week lows.
-
4 years ago benzinga.com
Why Crypto-Related Companies Traded Higher; Here Are 72 Biggest Movers From Yesterday
Gainers Applied Blockchain, Inc. (NASDAQ: APLD) shares climbed 100% to close at $2.12 on Tuesday after the company reported a 200-megawatt five-year hosting contract with Marathon Digital Holdings…
-
4 years ago benzinga.com
This Financial Services Stock Is Trading Higher By 50%, Here Are 40 Stocks Moving In Tuesday's Mid-Day Session
Gainers Applied Blockchain, Inc. (NASDAQ: APLD) jumped 50.1% to $1.5907 after the company reported a 200-megawatt five-year hosting contract with Marathon Digital Holdings and raised its Q4 revenue…
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 269 companies set new 52-week lows.
-
4 years ago benzinga.com
24 Stocks Moving in Friday's Pre-Market Session
Gainers Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 35% to $3.47 in pre-market trading. Vinco Ventures set record date as May 18, 2022 For dividend of shares related to Cryptyde deal. The…
-
4 years ago benzinga.com
32 Stocks Moving in Thursday's Pre-Market Session
Gainers Imperial Petroleum Inc. (NASDAQ: IMPP) rose 45.1% to $1.64 in pre-market trading after gaining around 41% on Wednesday.
-
5 years ago benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For October 25, 2021
Benzinga's Top Ratings Upgrades, Downgrades For October 25, 2021
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
Monday morning saw 558 companies set new 52-week highs.
-
5 years ago benzinga.com
36 Stocks Moving in Thursday's Pre-Market Session
Gainers Senseonics Holdings, Inc. (NYSE: SENS) shares rose 79.7% to $1.16 in pre-market trading after the company lifted its sales guidance for the fourth quarter. The company said it now expects Q4…
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
Before 10 a.m. ET Thursday, 132 stocks made new 52-week lows.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Monday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
Stocks That Hit 52-Week Lows On Friday
-
6 years ago benzinga.com
The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares
The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares
-
7 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
Stocks That Hit 52-Week Lows On Tuesday
-
7 years ago benzinga.com
Stocks Which Set New 52-Week High Yesterday, Mon., Dec. 3, 2018
Stocks Which Set New 52-Week High Yesterday, Mon., Dec. 3, 2018
-
8 years ago benzinga.com
56 Stocks Moving In Thursday's Mid-Day Session
56 Stocks Moving In Thursday's Mid-Day Session